A mother from Oxford, England, is facing an arduous battle against an aggressive form of brain cancer, following a series of misdiagnoses that put her life in jeopardy. Michelle Dilger, 60, was first diagnosed with glioblastoma in November 2018, almost a year after she began exhibiting alarming symptoms that were initially attributed to menopause and anxiety.
:max_bytes(150000):strip_icc():format(jpeg)/Michelle-Dilger189-06232026-f0c24496d37e4fa5823bfbb98fc52d9d.jpg)
At the age of 52, Michelle began to experience confusion and difficulties with her speech. Her son, Jack Dilger, 29, revealed that her once sharp mind and attention to detail began to falter, causing her to send messages that lacked coherent meaning. “My mum is an incredibly intelligent woman,” Jack reflected. “Then suddenly, she started sending messages that didn’t really make sense. Her speech became confused and disjointed.”
Despite her family’s growing concern, Michelle visited accident and emergency services multiple times, where her symptoms continued to be dismissed. Medical professionals who had been familiar with her for decades attributed her issues to standard conditions such as menopause and anxiety. “You trust what GPs tell you, because you want to believe everything is okay,” Jack explained, recalling the frustration of watching his mother suffer without receiving proper care.
It was only during a routine gynaecology appointment, where her doctor noticed her deteriorating state, that Michelle was urgently referred for a scan. The results were shocking; within half an hour, she was informed that she had a brain tumour. Jack recounted the moment he received the calamitous news from his father: “He was so distraught I could barely understand him. He said, ‘Your mum’s got a brain tumour’, and I felt like the ground had fallen beneath me.”
Michelle’s diagnosis came with devastating implications, as glioblastoma is known for its aggressive nature and lack of viable treatments. Given a prognosis of just 12 to 18 months to live, even with intervention, she began her battle against the cruel disease. Standard treatment often includes surgery followed by radiation and chemotherapy, yet the median survival rate for those diagnosed with this malignancy hovers around 14 months.
In the face of adversity, Michelle underwent surgery that successfully removed approximately 97% of the tumour. Shortly after the operation, she managed to regain her ability to speak, allowing her to commence further treatment, including six weeks of radiation therapy and twelve rounds of chemotherapy. Jack reported that this process took a significant toll on her physical health, but noted her remarkable resilience. “My mum is incredibly claustrophobic and really feared the MRI scanners, the masks, and even the appointments. Despite everything, Mum has never complained once,” he declared proudly.
The family celebrated each milestone as Michelle persevered through her treatment, but in early 2023, the tumour tragically returned. This time, however, she faced numerous complications, leading to an unexpected series of 13 brain surgeries within just two years. As a result, she now grapples with continued speech difficulties and weakness on the right side of her body.
Motivated by his mother’s journey, Jack has taken it upon himself to advocate for brain tumour research. He established a sports performance brand, Cramp Killa, with a commitment to donate a portion of the proceeds to the charity Brain Tumour Research, as he aims to raise awareness and support scientific research into the condition. “If Cramp Killa can become part of that journey while helping fund research into brain tumours, that would mean everything to me,” Jack said, expressing his hope that the athletic community would rally behind the cause.
Jack’s efforts resonate with Dan Knowles, chief executive of Brain Tumour Research, who stated that Michelle’s experience serves as a crucial reminder of the urgent need for advanced research. He commended Jack for his contributions, noting, “Our scientists are working tirelessly to unravel the underlying biology of these dreadful tumours and uncover new ways to attack them. This invaluable partnership with Cramp Killa will help fuel new discoveries and pave the way to smarter, kinder treatments for patients.”
Despite the challenging path that lies ahead, Jack remains steadfast in his belief that hope is not lost for his mother or others affected by this life-threatening disease. “As traumatic as this journey has been, we haven’t, and we never will, give up hope for my mum and others,” he stated, underscoring the importance of family solidarity in the face of life-altering adversity. Michelle’s story is not just a tale of struggle; it is a clarion call for greater awareness and support for research into a disease that continues to affect countless families.